• Развитие иммунного ответа при пневмонии, вызванной Pseudomonas aeruginosa (часть 2) 

Развитие иммунного ответа при пневмонии, вызванной Pseudomonas aeruginosa (часть 2) 

SOVREMENNAYA PEDIATRIYA.2016.8(80):59-64; doi 10.15574/SP.2016.80.59 

Развитие иммунного ответа при пневмонии, вызванной Pseudomonas aeruginosa (часть 2) 

Абатуров А. Е., Никулина А. А. 
ГУ «Днепропетровская медицинская академия МЗ Украины», г. Днепр, Украина


В статье на основании литературных данных проанализирована ключевая роль провоспалительных и противовоспалительных цитокинов в развитии иммунного ответа при пневмонии, вызванной Pseudomonas aeruginosa. Описаны сигнальные пути, индуцирующие продукцию интерферонов І и ІІІ типа, участвующие в элиминации Pseudomonas aeruginosa.


Ключевые слова: пневмония, Pseudomonas aeruginosa, цитокины, интерфероны І и ІІІ типа.


Литература

1. Абатуров А. Е. Индукция молекулярных механизмов неспецифической защиты респираторного тракта / А. Е. Абатуров, А. П. Волосовец, Е. И. Юлиш. — Київ : Приватна друкарня ФО-II, Сторожук О.В., 2012. — 240 с.

2. Al Moussawi K. Distinct contributions of interleukin-1α (IL-1α) and IL-1β to innate immune recognition of Pseudomonas aeruginosa in the lung / K. Al Moussawi, B. I. Kazmierczak // Infect Immun. — 2014. — Vol. 82 (10). — P. 4204-11. https://doi.org/10.1128/IAI.02218-14.

3. An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia / A. M. Hajjar, H. Harowicz, H. D. Liggitt [et al.] // Am. J. Respir. Cell Mol Biol. — 2005. — Vol. 33 (5). — P. 470—5. https://doi.org/10.1165/rcmb.2005-0199OC.

4. Associations between TNF-α polymorphisms and pneumonia: a meta-analysis / L. Li, W. Nie, W. Li [et al.] // PLoS One. — 2013. — Vol. 8 (4):e61039. https://doi.org/10.1371/journal.pone.0061039.

5. Borthwick L. A. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung / L. A. Borthwick // Semin. Immunopathol. — 2016. — Vol. 38 (4). — P. 517—34. https://doi.org/10.1007/s00281-016-0559-z.

6. Boxx G. M. The Roles of Type I Interferon in Bacterial Infection / G. M. Boxx, G. Cheng // Cell Host Microbe. — 2016. — Vol. 19 (6). — P. 760-9. https://doi.org/10.1016/j.chom.2016.05.016.

7. Broz P. Inflammasome assembly: The wheels are turning / P. Broz // Cell Res. 2015. — Vol. 25 (12). — P. 1277—8. https://doi.org/10.1038/cr.2015.137.

8. Cohen T. S. Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia / T. S. Cohen, A. S. Prince // J. Clin. Invest. — 2013. —Vol. 123 (4). — P. 1630—7. https://doi.org/10.1172/JCI66142.

9. Cohen T. S. Bacterial pathogens activate a common inflammatory path-way through IFNl regulation of PDCD4 / T. S. Cohen, A. S. Prince // PLoS Pathog. 2013. — Vol. 9 (10):e1003682. https://doi.org/10.1371/journal.ppat.1003682.

10. Cohen T. S. Microbial pathogenesis and type III interferons / T. S. Cohen, D. Parker // Cytokine Growth Factor Rev. — 2016. — Vol. 29. — P. 45—51. https://doi.org/10.1016/j.cytogfr.2016.02.005.

11. Cyktor J. C. Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens / J. C. Cyktor, J. Turner // Infect Immun. — 2011. —Vol. 79 (8). — P. 2964—73. https://doi.org/10.1128/IAI.00047-11.

12. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis(induced immune dysfunction / F. Pene, B. Zuber, E. Courtine [et al.] // J. Immunol. — 2008. — Vol. 181 (12). — P. 8513—20. doi 10.4049/ jimmunol.181.12.8513.

13. Dubin P. J. IL-17 in cystic fibrosis: more than just Th17 cells / P. J. Dubin, J. K. Kolls // Am. J. Respir. Crit. Care Med. — 2011. — Vol. 184 (2). — P. 155—7. https://doi.org/10.1164/rccm.201104-0617ED.

14. Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge / L. Sun, R. F. Guo, M. W. Newstead [et al.] // Am. J. Respir. Cell Mol. Biol. — 2009. — Vol. 41 (1). — P. 76—84. https://doi.org/10.1165/rcmb.2008-0202OC.

15. Emerging Concepts about NAIP/NLRC4 Inflammasomes / S. L. Lage, C. Longo, L. M. Branco [et al.] // Front Immunol. — 2014. — Vol. 5. — P. 309. https://doi.org/10.3389/fimmu.2014.00309.

16. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways / M. Miyamoto, O. Prause, M. Sjostrand [et al.] // J. Immunol. — 2003. — Vol. 170 (9). — P. 4665—72. https://doi.org/10.4049/jimmunol.170.9.4665.

17. Farias R. The TAK1→IKKβ→TPL2→MKK1/MKK2 Signaling Cascade Regulates IL-33 Expression in Cystic Fibrosis Airway Epithelial Cells Following Infection by Pseudomonas aeruginosa / R. Farias, S. Rousseau // Front Cell Dev Biol. — 2016. — Vol. 3. — P. 87. https://doi.org/10.3389/fcell.2015.00087.

18. Hazlett L. D. IL-10 function, regulation, and in bacterial keratitis / L. D. Hazlett, X. Jiang, S. A. McClellan // J. Ocul. Pharmacol. Ther. — 2014. — Vol. 30 (5). — P. 373—80. https://doi.org/10.1089/jop.2014.0018.

19. Heat-shock response increases lung injury caused by Pseudomonas aeruginosa via an interleukin-10-dependent mechanism in mice / M. Carles, B. M. Wagener, M. Lafargue [et al.] // Anesthesiology. — 2014. — Vol. 120 (6). — P. 1450—62. https://doi.org/10.1097/ALN.0000000000000235.

20. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice / S. O. Carrigan, R. Junkins, Y. J. Yang [et al.] // J. Immunol. — 2010. — Vol. 185 (6). — P. 3602—9. https://doi.org/10.4049/jimmunol.0903429.

21. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia / T. Sawa, D. B. Corry, M. A. Gropper [et al.] // J. Immunol. — 1997. — Vol. 159 (6). — P. 2858—66. PMID: 9300709.; PMid:9300709.

22. IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa / N. I. Lore, C. Cigana, C. Riva [et al.] // Sci Rep. — 2016. — Vol. 6. — P. 25937. https://doi.org/10.1038/srep25937.

23. IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-gamma production / X. Huang, S. A. McClellan, R. P. Barrett, L. D. Hazlett // J. Immunol. — 2002. — Vol. 168 (11). — P. 5756—63.doi 10.4049/ jimmunol.168.11.5756.

24. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis / L. D. Hazlett, S. A. McClellan, R. P. Barrett [et al.] // Invest Ophthalmol Vis Sci. — 2010. — Vol. 51 (3). — P. 1524—32. https://doi.org/10.1167/iovs.09-3983.

25. IL-33 Signaling in Lung Injury / J. Chang, Y. F. Xia, M. Z. Zhang, L. M. Zhang // Transl. Perioper Pain Med. — 2016. — Vol. 1 (2). — P. 24—32. PMid:27536706 PMCid:PMC4985245.

26. Immunoregulatory effects of regulated, lung-targeted expression of IL(10 in vivo / D. Spight, B. Zhao, M. Haas [et al.] // Am. J. Physiol. Lung Cell Mol. Physiol. — 2005. — Vol. 288 (2):L251—65. https://doi.org/10.1152/ajplung.00122.2004; PMid:15466252

27. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells / D. Parker, T. S. Cohen, M. Alhede [et al.] // Am. J. Respir. Cell Mol Biol. — 2012. — Vol. 46 (1). — P. 6—13. https://doi.org/10.1165/rcmb.2011-0080OC.

28. Innate Immune Signaling Activated by MDR Bacteria in the Airway / D. Parker, D. Ahn, T. Cohen, A. Prince // Physiol Rev. — 2016. — Vol. 96 (1). — P. 19—53. https://doi.org/10.1152/physrev.00009.2015.

29. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia / Y. Shindo, A. G. Fuchs, C. G. Davis [et al.] // J. Leukoc Biol. — 2016. — Sep. 14. pii: jlb.4A1215—581R.

30. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation / Hsu D., Taylor P., Fletcher D. [et al.] // Infect Immun. — 2016. — Vol. 84 (9). — P. 2410—21. https://doi.org/10.1128/IAI.00284-16.

31. Interleukin-18 and IL-18 binding protein / C. A. Dinarello, D. Novick, S. Kim, G. Kaplanski // Front. Immunol. — 2013. — Vol. 4. — P. 289. https://doi.org/10.3389/fimmu.2013.00289.

32. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa / M. J. Schultz, S. Knapp, S. Florquin [et al.] // Infect. Immun. — 2003. — Vol. 71 (4). — P. 1630—4. https://doi.org/10.1128/IAI.71.4.1630-1634.2003.

33. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection / J. C. Alves-Filho, F. Sonego, F.O. Souto [et al.] // Nat. Med. — 2010. — Vol. 16 (6). — P. 708—12. https://doi.org/10.1038/nm.2156.

34. Lambda Interferons: New Cytokines with Old Functions / O. J. Hamming, H. H. Gad, S. Paludan, R. Hartmann // Pharmaceuticals (Basel). — 2010. — Vol. 3 (4). — P. 795—809. https://doi.org/10.3390/ph3040795.

35. Lavoie E. G. Innate immune responses to Pseudomonas aeruginosa infection / E. G. Lavoie, T. Wangdi, B. I. Kazmierczak // Microbes Infect. — 2011. —Vol. 13 (14—15). — P. 1133—45. https://doi.org/10.1016/j.micinf.2011.07.011.

36. Liew F. Y. Interleukin-33 in health and disease / F. Y. Liew, J. P. Girard, H. R. Turnquist // Nat. Rev. Immunol. — 2016. — Sep. 19. https://doi.org/10.1038/nri.2016.95.

37. Limited role for interleukin(18 in the host protection response to pulmonary infection with Pseudomonas aeruginosa in mice / C. Nakasone, K. Kawakami, T. Hoshino [et al.] // Infect. Immun. — 2004. — Vol. 72 (10). — P. 6176—80. https://doi.org/10.1128/IAI.72.10.6176-6180.2003.

38. Lung function and inflammation during murine Pseudomonas aeruginosa airway infection / F. Wolbeling, A. Munder, T. Kerber(Momot [et al.] // Immunobiology. — 2011. — Vol. 216 (8). — P. 901—8. https://doi.org/10.1016/j.imbio.2011.02.003

39. Modulation of bacterial growth by tumor necrosis factor-alpha in vitro and in vivo / J. H. Lee, L. Del Sorbo, A. A. Khine [et al.] // Am. J. Respir. Crit Care Med. — 2003. — Vol. 168 (12). — P. 1462—70. https://doi.org/10.1164/rccm.200302-303OC.

40. Molofsky A. B. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation / A. B. Molofsky, A. K. Savage, R. M. Locksley // Immunity. — 2015. — Vol. 42 (6). — P. 1005—19. https://doi.org/10.1016/j.immuni.2015.06.006.

41. Neutrophil-derived tumor necrosis factor-α contributes to acute wound healing promoted by N-(3-oxododecanoyl)-L-homoserine lactone from Pseudomonas aeruginosa / E. Kanno, K. Kawakami, S. Miyairi [et al.] // J. Dermatol. Sci. — 2013. — Vol. 70 (2). — P. 130—8. https://doi.org/10.1016/j.jdermsci.2013.01.004.

42. Novick D. Interleukin-18, more than a Th1 cytokine / D. Novick, S. Kim, G. Kaplanski, C. A. Dinarello // Semin Immunol. 2013 Dec 15; 25(6): 439—48. https://doi.org/10.1016/j.smim.2013.10.014.

43. Patankar Y. R. Differential ASC requirements reveal a key role for neutrophils and a noncanonical IL-1β response to Pseudomonas aeruginosa / Y. R. Patankar, R. Mabaera, B. Berwin // Am. J. Physiol. Lung Cell Mol Physiol. — 2015. — Vol. 309 (8):L902—13. https://doi.org/10.1152/ajplung.00228.2015.

44. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice / J. F. Chmiel, M. W. Konstan, A. Saadane [et al.] // Am. J. Respir. Crit. Care Med. — 2002. — Vol. 165 (8). — P. 1176—81. https://doi.org/10.1164/ajrccm.165.8.2107051.

45. Protein Tyrosine Phosphatase-1B Negatively Impacts Host Defense against Pseudomonas aeruginosa Infection / L. Yue, Z. Xie, H. Li [et al.] // Am. J. Pathol. — 2016. — Vol. 186 (5). — P. 1234—44. https://doi.org/10.1016/j.ajpath.2016.01.005.

46. Pseudomonas aeruginosa colonization enhances ventilator-associated pneumonia-induced lung injury / T. B. Tsay, Y. Z. Jiang, C. M. Hsu, L. W. Chen // Respir. Res. — 2016. — Vol. 17 (1). — P. 101. https://doi.org/10.1186/s12931-016-0417-5.

47. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome / E. Faure, J. B. Mear, K. Faure [et al.] // Am. J. Respir. Crit. Care Med. — 2014. — Vol. 189 (7). — P. 799—811. https://doi.org/10.1164/rccm.201307-1358OC.

48. Rathore J. S. Protective role of Th17 cells in pulmonary infection / J. S. Rathore, Y. Wang // Vaccine. — 2016. — Vol. 34 (13). — P. 1504—14. https://doi.org/10.1016/j.vaccine.2016.02.021.

49. Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa / M. Kinoshita, N. Shinomiya, S. Ono [et al.] // J. Immunol. — 2006. — Vol. 177 (7). — P. 4627—35. https://doi.org/10.4049/jimmunol.177.7.4627.

50. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection / J. Palomo, T. Marchiol, J. Piotet [et al.] // PLoS One. — 2014. — Vol. 9 (12):e114884. https://doi.org/10.1371/journal.pone.0114884.

51. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia / M. J. Schultz, A. W. Rijneveld, S. Florquin [et al.] // Am. J. Physiol. Lung Cell Mol. Physiol. — 2002. — Vol. 282 (2):L285—90. https://doi.org/10.1152/ajplung.00461.2000; PMid:11792633

52. Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungs / X. Xu, B. Shao, R. Wang [et al.] // Int. J. Clin. Exp. Med. — 2014. —Vol. 7 (4). — P. 809—16. PMID: 24955149. PMid:24955149 PMCid:PMC4057828.

53. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa / S. J. Skerrett, T. R. Martin, E. Y. Chi [et al.] // Am. J. Physiol. — 1999. — Vol. 276 (5 Pt 1): L715—27. PMid:10330027.

54. Roy S. CD14 mediates Toll-like receptor 4 (TLR4) endocytosis and spleen tyrosine kinase (Syk) and interferon regulatory transcription factor 3 (IRF3) activation in epithelial cells and impairs neutrophil infiltration and Pseudomonas aeruginosa killing in vivo / S. Roy, M. Karmakar, E. Pearlman // J. Biol. Chem. — 2014. — Vol. 289 (2). — P. 1174—82. https://doi.org/10.1074/jbc.M113.523167.

55. Structural basis of cell apoptosis and necrosis in TNFR signaling / J. Huang, S. Yu, C. Ji, J. Li // Apoptosis. — 2015. — Vol. 20 (2). — P. 210—5. https://doi.org/10.1007/s10495-014-1061-5.

56. The IL(17A/IL(17RA axis in pulmonary defence and immunopathology / N. I. Lore, A. Bragonzi, C. Cigana [et al.] // Cytokine Growth Factor Rev. — 2016. — Vol. 30. — P. 19—27. https://doi.org/10.1016/j.cytogfr.2016.03.009.

57. The responses of γδ T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17 / J. Liu, H. Qu, Q. Li [et al.] // Pathog Dis. — 2013. — Vol. 68 (2). — P. 44—51. doi 10.1111/2049632X.12043.

58. The role of IL-1β in Pseudomonas aeruginosa in lung infection / B. Wonnenberg, M. Bischoff, C. Beisswenger [et al.] // Cell. Tissue Res. — 2016. — Vol. 364 (2). — P. 225—9. https://doi.org/10.1007/s00441-016-2387-9.

59. TNF-α is a key regulator of MUC1, an anti-inflammatory molecule, during airway Pseudomonas aeruginosa infection / S. Choi, Y. S. Park, T. Koga [et al.] // Am. J. Respir. Cell Mol. Biol. — 2011. — Vol. 44 (2). — P. 255—60. https://doi.org/10.1165/rcmb.2009-0323OC.

60. Xiao M. The Role of Proinflammatory Cytokine Interleukin-18 in Radiation Injury / M. Xiao // Health Phys. — 2016. — Vol. 111 (2). — P. 212—7. doi 10.1097/HP. 0000000000000494.